AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Vahakangas, K
Citation: K. Vahakangas, Ethical implications of genetic analysis of individual susceptibility to diseases, MUT RES-F M, 482(1-2), 2001, pp. 105-110

Authors: Rapakko, K Allinen, M Syrjakoski, K Vahteristo, P Huusko, P Vahakangas, K Eerola, H Kainu, T Kallioniemi, OP Nevanlinna, H Winqvist, R
Citation: K. Rapakko et al., Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites, BR J CANC, 84(1), 2001, pp. 116-119

Authors: Hakkola, J Raunio, H Purkunen, R Saarikoski, S Vahakangas, K Pelkonen, O Edwards, RJ Boobis, AR Pasanen, M
Citation: J. Hakkola et al., Cytochrome P450 3A expression in the human fetal liver: Evidence that CYP3A5 is expressed in only a limited number of fetal livers, BIOL NEONAT, 80(3), 2001, pp. 193-201

Authors: Ala-Kokko, TI Myllynen, P Vahakangas, K
Citation: Ti. Ala-kokko et al., Ex vivo perfusion of the human placental cotyledon: implications for anesthetic pharmacology, INT J OB AN, 9(1), 2000, pp. 26-38

Authors: Zheng, A Mantymaa, P Saily, M Savolainen, ER Vahakangas, K Koistinen, P
Citation: A. Zheng et al., p53 pathway in apoptosis induced by all-trans-retinoic acid in acute myeloblastic leukaemia cells, ACT HAEMAT, 103(3), 2000, pp. 135-143

Authors: Olivero, OA Parikka, R Poirier, MC Vahakangas, K
Citation: Oa. Olivero et al., 3 '-azido-3 '-deoxythymidine (AZT) transplacental perfusion kinetics and DNA incorporation in normal human placentas perfused with AZT, MUT RES-F M, 428(1-2), 1999, pp. 41-47

Authors: Huusko, P Castren, K Launonen, V Soini, Y Paakkonen, K Leisti, J Vahakangas, K Winqvist, R
Citation: P. Huusko et al., Germ-line TP53 mutations in Finnish cancer families exhibiting features ofthe Li-Fraumeni syndrome and negative for BRCA1 and BRCA2, CANC GENET, 112(1), 1999, pp. 9-14

Authors: Serpi, R Piispala, J Jarvilehto, M Vahakangas, K
Citation: R. Serpi et al., Thapsigargin has similar effect on p53 protein response to benzo[a]pyrene-DNA adducts as TPA in mouse skin, CARCINOGENE, 20(9), 1999, pp. 1755-1760

Authors: Zheng, A Castren, K Saily, M Savolainen, ER Koistinen, P Vahakangas, K
Citation: A. Zheng et al., p53 status of newly established acute myeloid leukaemia cell lines, BR J CANC, 79(3-4), 1999, pp. 407-415

Authors: Hannuksela-Svahn, A Paakka, P Autio, P Reunala, T Karvonen, J Vahakangas, K
Citation: A. Hannuksela-svahn et al., Expression of p53 protein before and after PUVA treatment in psoriasis, ACT DER-VEN, 79(3), 1999, pp. 195-199

Authors: Myllynen, P Pienimaki, P Raunio, H Vahakangas, K
Citation: P. Myllynen et al., Microsomal metabolism of carbamazepine and oxcarbazepine in liver and placenta, HUM EXP TOX, 17(12), 1998, pp. 668-676
Risultati: 1-11 |